Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Shares Outstanding (Weighted Average): 2017-2024

Historic Shares Outstanding (Weighted Average) for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to $91.5 million.

  • Arcus Biosciences' Shares Outstanding (Weighted Average) rose 16.41% to $106.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.4 million, marking a year-over-year increase of 16.41%. This contributed to the annual value of $91.5 million for FY2024, which is 22.25% up from last year.
  • Arcus Biosciences' Shares Outstanding (Weighted Average) amounted to $91.5 million in FY2024, which was up 22.25% from $74.9 million recorded in FY2023.
  • In the past 5 years, Arcus Biosciences' Shares Outstanding (Weighted Average) registered a high of $91.5 million during FY2024, and its lowest value of $64.9 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $79.6 million, with a median of $74.9 million in 2023.
  • Data for Arcus Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 41.57% (in 2020) over the last 5 years.
  • Over the past 5 years, Arcus Biosciences' Shares Outstanding (Weighted Average) (Yearly) stood at $64.9 million in 2020, then increased by 8.20% to $70.2 million in 2021, then increased by 3.07% to $72.4 million in 2022, then climbed by 3.38% to $74.9 million in 2023, then grew by 22.25% to $91.5 million in 2024.